Chair: Good morning distinguished delegates, ladies and gentlemen. It is a great honour for me as chair of the CND to welcome you to the reconvened 63rd session of the Commission. I would like to start our meeting today with a few organisational arrangements. As you are aware, the World Health Organisation has declared the …
Cyprus
Plenary: Item 4. General debate of the ministerial segment (cont…)
Chair: Good morning, we’ll now resume the session. We have many on the list. Secretary: We have nearly 70 speakers left that have asked for the floor. We will do our very best – but we’ll have to have another evening session tonight to accommodate. We’d like to appeal to the speakers – some of …
Plenary: Item 3 General Debate (Tuesday 13th – Morning Session)
Mexico: We meet because of our interest to tackle the World Drug Problem. Aware of the progress made so far, Mexico would like to strengthen the work of the CND in ordinary meetings, subsidiaries and intersessional. For Mexico it is important to replicate the good practice of this process. The implementation of the UNGASS document is …
CND Intersessional, 16 October 2017: Chapter 3 on supply reduction, law enforcement, responses to drug-related crime and countering money laundering
Amb. Bente Angell-Hansen, CND Chair: I welcome all attending for joining us in this important work, as well as the panellists on this session. I invite the meeting to adopt the provisional agenda. It is adopted. In order to use our time effectively, I’d like to start this meeting with Agenda Item 2 on the …
UNGASS: Thirtieth special session of the General Assembly on the world drug problem (5th plenary meeting)
The full statements delivered by member states during the UNGASS general debate are available here. President of Peru: The new government has increased development in our country and has made a big difference in terms access to drinking water and other factors. We have diversified the crop growth in our country and increased crops such …
UNGASS Roundtable 1: Demand reduction and related measures
Demand reduction and related measures, including prevention and treatment, as well as health-related issues; an ensuring the availability of controlled substances for medical and scientific purposes, while preventing their diversion. (‘Drugs and health’) Chair: in order to encourage an interactive discussion, this will be conducted without a list of speakers. All participants at round tables …